Jin Medical International Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of April 2026 for Jin Medical International Ltd., a Cayman Islands exempted company. The report primarily addresses the company's compliance status with The Nasdaq Stock Market LLC regarding Listing Rule 5550(a)(2), the Minimum Bid Price Requirement.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and listing compliance matters.
Material Changes
- Regained Nasdaq Compliance: On April 2, 2026, the company received written notice from Nasdaq confirming it regained compliance with the Minimum Bid Price Requirement. The closing bid price remained at or above $1.00 per share for 13 consecutive business days (March 16, 2026, to April 1, 2026).
- Share Consolidation: A 1-for-20 share consolidation of Class A and Class B ordinary shares, approved by the Board on February 3, 2026, became effective on March 16, 2026. This action was taken to address prior non-compliance with the minimum bid price rule.
- Capital Structure Update: Following the consolidation, the authorized share capital is US$50,000, divided into 45,000,000 Class A ordinary shares and 5,000,000 Class B ordinary shares. As of April 7, 2026, there are 6,827,355 Class A shares and 1,000,000 Class B shares issued and outstanding.
Outlook, Risks, and Management Commentary
Management commentary indicates that the share consolidation was the primary mechanism used to restore the stock price to the required $1.00 threshold. The company had previously received a deficiency letter in May 2025 and was granted two consecutive 180-day compliance periods, the second of which ended on April 29, 2026. The filing notes that the report is incorporated by reference into the company's Form F-3 registration statement.
Investor Verification Checklist
- Verify the current trading volume and price stability of the post-consolidation shares to ensure continued compliance with Nasdaq rules.
- Review the company's most recent Form 20-F (filed February 10, 2026) for detailed financial performance data not included in this 6-K.
- Confirm the exact number of shares outstanding and the impact of the 1-for-20 consolidation on shareholder ownership percentages.
- Monitor for any future deficiency notices if the bid price falls below $1.00 again.